562 related articles for article (PubMed ID: 32437876)
1. Drug rechanneling: A novel paradigm for cancer treatment.
Kaushik I; Ramachandran S; Prasad S; Srivastava SK
Semin Cancer Biol; 2021 Jan; 68():279-290. PubMed ID: 32437876
[TBL] [Abstract][Full Text] [Related]
2. Repurposing psychiatric drugs as anti-cancer agents.
Huang J; Zhao D; Liu Z; Liu F
Cancer Lett; 2018 Apr; 419():257-265. PubMed ID: 29414306
[TBL] [Abstract][Full Text] [Related]
3. Computer-aided drug repurposing for cancer therapy: Approaches and opportunities to challenge anticancer targets.
Mottini C; Napolitano F; Li Z; Gao X; Cardone L
Semin Cancer Biol; 2021 Jan; 68():59-74. PubMed ID: 31562957
[TBL] [Abstract][Full Text] [Related]
4. Drug repurposing in cancer.
Sleire L; Førde HE; Netland IA; Leiss L; Skeie BS; Enger PØ
Pharmacol Res; 2017 Oct; 124():74-91. PubMed ID: 28712971
[TBL] [Abstract][Full Text] [Related]
5. Repurposing of drugs: An attractive pharmacological strategy for cancer therapeutics.
Kirtonia A; Gala K; Fernandes SG; Pandya G; Pandey AK; Sethi G; Khattar E; Garg M
Semin Cancer Biol; 2021 Jan; 68():258-278. PubMed ID: 32380233
[TBL] [Abstract][Full Text] [Related]
6. Turning liabilities into opportunities: Off-target based drug repurposing in cancer.
Palve V; Liao Y; Remsing Rix LL; Rix U
Semin Cancer Biol; 2021 Jan; 68():209-229. PubMed ID: 32044472
[TBL] [Abstract][Full Text] [Related]
7. Phyotochemical candidates repurposing for cancer therapy and their molecular mechanisms.
Jung JH; Hwang J; Kim JH; Sim DY; Im E; Park JE; Park WY; Shim BS; Kim B; Kim SH
Semin Cancer Biol; 2021 Jan; 68():164-174. PubMed ID: 31883914
[TBL] [Abstract][Full Text] [Related]
8. Repurposing Drugs in Oncology: Next Steps.
Verbaanderd C; Meheus L; Huys I; Pantziarka P
Trends Cancer; 2017 Aug; 3(8):543-546. PubMed ID: 28780930
[TBL] [Abstract][Full Text] [Related]
9. Drug repurposing-an emerging strategy in cancer therapeutics.
Turabi KS; Deshmukh A; Paul S; Swami D; Siddiqui S; Kumar U; Naikar S; Devarajan S; Basu S; Paul MK; Aich J
Naunyn Schmiedebergs Arch Pharmacol; 2022 Oct; 395(10):1139-1158. PubMed ID: 35695911
[TBL] [Abstract][Full Text] [Related]
10. Repurposing approved non-oncology drugs for cancer therapy: a comprehensive review of mechanisms, efficacy, and clinical prospects.
Mohi-Ud-Din R; Chawla A; Sharma P; Mir PA; Potoo FH; Reiner Ž; Reiner I; Ateşşahin DA; Sharifi-Rad J; Mir RH; Calina D
Eur J Med Res; 2023 Sep; 28(1):345. PubMed ID: 37710280
[TBL] [Abstract][Full Text] [Related]
11. Drug repurposing for cancer therapy, easier said than done.
Gonzalez-Fierro A; Dueñas-González A
Semin Cancer Biol; 2021 Jan; 68():123-131. PubMed ID: 31877340
[TBL] [Abstract][Full Text] [Related]
12. Repurposing existing therapeutics, its importance in oncology drug development: Kinases as a potential target.
Islam S; Wang S; Bowden N; Martin J; Head R
Br J Clin Pharmacol; 2022 Jan; 88(1):64-74. PubMed ID: 34192364
[TBL] [Abstract][Full Text] [Related]
13. Protective role of anticancer drugs in neurodegenerative disorders: A drug repurposing approach.
Advani D; Gupta R; Tripathi R; Sharma S; Ambasta RK; Kumar P
Neurochem Int; 2020 Nov; 140():104841. PubMed ID: 32853752
[TBL] [Abstract][Full Text] [Related]
14. Old drugs, new uses: Drug repurposing in hematological malignancies.
Kale VP; Habib H; Chitren R; Patel M; Pramanik KC; Jonnalagadda SC; Challagundla K; Pandey MK
Semin Cancer Biol; 2021 Jan; 68():242-248. PubMed ID: 32151704
[TBL] [Abstract][Full Text] [Related]
15. Drug Repurposing in the Development of Anticancer Agents.
Olgen S; Kotra LP
Curr Med Chem; 2019; 26(28):5410-5427. PubMed ID: 30009698
[TBL] [Abstract][Full Text] [Related]
16. Recent Drug-Repurposing-Driven Advances in the Discovery of Novel Antibiotics.
Konreddy AK; Rani GU; Lee K; Choi Y
Curr Med Chem; 2019; 26(28):5363-5388. PubMed ID: 29984648
[TBL] [Abstract][Full Text] [Related]
17. Machine and deep learning approaches for cancer drug repurposing.
Issa NT; Stathias V; Schürer S; Dakshanamurthy S
Semin Cancer Biol; 2021 Jan; 68():132-142. PubMed ID: 31904426
[TBL] [Abstract][Full Text] [Related]
18. Drug repositioning in cancer: The current situation in Japan.
Masuda T; Tsuruda Y; Matsumoto Y; Uchida H; Nakayama KI; Mimori K
Cancer Sci; 2020 Apr; 111(4):1039-1046. PubMed ID: 31957175
[TBL] [Abstract][Full Text] [Related]
19. Repurposing drugs in oncology: From candidate selection to clinical adoption.
Pantziarka P; Verbaanderd C; Huys I; Bouche G; Meheus L
Semin Cancer Biol; 2021 Jan; 68():186-191. PubMed ID: 31982510
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive review of the repositioning of non-oncologic drugs for cancer immunotherapy.
Rauf A; Joshi PB; Olatunde A; Hafeez N; Ahmad Z; Hemeg HA; Aljohani ASM; Al Abdulmonem W; Thiruvengadam M; Viswanathan D; Rajakumar G; Thiruvengadam R
Med Oncol; 2024 Apr; 41(5):122. PubMed ID: 38652344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]